Alzheimers Disease Neuroimaging Initiative (ADNI)
A public-private partnership, the purpose of ADNI is to develop a multisite, longitudinal, prospective, naturalistic study of normal cognitive aging, mild cognitive impairment (MCI), and early Alzheimer's disease as a public domain research resource to facilitate the scientific evaluation of neuroimaging and other biomarkers for the onset and progression of MCI and Alzheimer's disease.
Dr. Laurie Ryan of the NIA gives a brief overview of ADNI in this video:
Dr. Thomas Obisesan of Howard University, an ADNI study participant, and a study companion describe ADNI and what it's like to be involved in the study:
A study participant talks about his commitment to ADNI:
Related Content
Get a sneak peek of concepts approved by the National Advisory Council on Aging.
Learn more about Alzheimer’s research implementation plans and progress.
Browse active NIA-funded Alzheimer’s and related dementias clinical trials and studies.